Table 1. Main characteristics of included studies in the meta-analysis.
Author | Year | Country | Duration Months | Patients Number | Detection Methods |
---|---|---|---|---|---|
Arima C[18] | 2014 | Japan | 91 | 126 | cDNA Microarray |
Cui ZS[19] | 2014 | China | 5 | 30 | Elisa |
He DP[20] | 2014 | China | 24 | 48 | RT-PCR, IHC |
He JJ[21] | 2012 | China | 40 | 65 | IHC |
Hou J[22] | 2010 | Netherlands | NR* | 82 | cDNA Microarray |
Karlsson A[23] | 2014 | Sweden | NR* | 121 | cDNA Microarray |
Kastner S | 2012 | Austria | NR* | 16 | cDNA Microarray |
Lo FY[24] | 2012 | Taiwan, China | NR* | 21 | cDNA Microarray |
Naumnik W[25] | 2009 | Poland | NR* | 40 | Elisa |
Rousseaux S[26] | 2013 | France | NR* | 272 | cDNA Microarray |
Shang GH[27] | 2009 | China | 42 | 145 | Elisa |
Shen X[28] | 2009 | China | 24 | 63 | RT-PCR, WB |
Su WM[29] | 2012 | China | 24 | 69 | IHC |
Wang FL[30] | 2009 | China | 7 | 53 | IHC |
Wang JY[31] | 2014 | China | 3 | 30 | Elisa, IHC |
Wang Y[32] | 2014 | China | 12 | 30 | RT-PCR, Elisa |
Xu SB[33] | 2009 | China | 48 | 52 | IHC |
Yang XM[34] | 2013 | China | 24 | 64 | RT-PCR |
Zhang SD[35] | 2011 | China | 24 | 95 | IHC |
Zhang X[36] | 2013 | China | 36 | 106 | IHC |
NR: not reporting.